Our offerings under Rule 506(c) are for accredited investors only.
FOR OUR CURRENT REGULATION A OFFERING, NO SALE MAY BE MADE TO YOU IN THIS OFFERING IF THE AGGREGATE PURCHASE PRICE YOU PAY IS MORE THAN 10% OF THE GREATER OF YOUR ANNUAL INCOME OR NET WORTH. DIFFERENT RULES APPLY TO ACCREDITED INVESTORS AND NON-NATURAL PERSONS. BEFORE MAKING ANY REPRESENTATION THAT YOUR INVESTMENT DOES NOT EXCEED APPLICABLE THRESHOLDS, WE ENCOURAGE YOU TO REVIEW RULE 251(D)(2)(I)(C) OF REGULATION A. FOR GENERAL INFORMATION ON INVESTING, WE ENCOURAGE YOU TO REFER TO WWW.INVESTOR.GOV. Our Offering Circular, which is part of the Offering Statement, may be found at sec.gov or on our website. www.cardonecapital.com/offering-1.

What Exercise Is Best For An Entrepreneur- David Karli

Public demand for emerging biomedical technologies is higher than ever. Patients, investors and philanthropic supporters find themselves in unfamiliar territory, now as consumers of cutting-edge medical options which require diligence and careful consideration.

There are little direction and sound resources for the patient consumer to understand the what, where and who(?) regarding investments of time, money and risk in fields like regenerative medicine and stem cell therapies, age management medicine, nutrition and supplementation and genetic testing.

The piece will introduce Dr. David Karli, who has had unique and intensive exposure to these emerging medical and scientific fields. Is tomorrow’s medicine here today? Is modern med-tech hope or hype?

www.davidkarli.com

(Visited 19 times, 1 visits today)